Health-care workers need to be able to use herbal medicine (AHMs) safely, but some of the ingredients used in the drugs can pose risks for people with heart conditions.
But now, a new drug-maker is taking the safety of herbal medicine to the next level by using a synthetic drug to make the pills.
According to the Journal of the American Medical Association (JAMA), Huawei Pharmaceuticals has developed a synthetic version of an AHM known as AZAZ (Bactroblumia Azulis Z.) to produce the pills that the company has been marketing as an AHMs treatment.
The drug was initially approved in Europe in 2009, and it is now available for sale in the United States.
The new product, which Huawei says is safer than the generic version, has received approval in Canada, and the U.K. in 2019.
Huawei says that its AZAZA synthetic AHM is not a placebo, and can also be used to treat people with high cholesterol, asthma, or allergies.
According to Huawei, the drug can treat patients with high blood pressure, stroke, heart failure, and cancer.
The new drug has been tested in humans, and Huawei says it has not found any adverse effects on the drug.
The company said that its product can be used safely and safely dispensed without any side effects.
“Huawei is committed to creating the most powerful and best-preserved synthetic AHMs on the market,” Huawei said in a statement.
But many experts believe that the new product is a major step backward.
“The generic AZAZE has been approved for human use in the U